Founder - DIPG Research
Clinical implications of recent FDA approvals for diffuse midline glioma with H3K27 variation (dordaviprone) - studies EXCLUDED pontine diffuse glioma, so can we say it works for DIPG?
Clinical implications of recent FDA approvals for diffuse midline glioma with H3K27 variation (dordaviprone) - studies EXCLUDED pontine diffuse glioma, so can we say it works for DIPG?
We are dedicated to work hard and advance this technology to humans.
www.media.mit.edu/posts/prof-d...
We are dedicated to work hard and advance this technology to humans.
www.media.mit.edu/posts/prof-d...
Read more about Sunnie’s story here: www.sunniestrong.org/about_us
Read more about Sunnie’s story here: www.sunniestrong.org/about_us